MODEL FOR LPS/PHOSPHOLIPIDS BIOSYNTHESIS Fatty acid biosynthesis in E. coli: an overview
Phospholipids are a major and essential component of the bacterial outer membrane. Each molecule consist of a glycerol moiety, a phosphate group, and two fatty acids (except for cardiolipins) (1). Therefore, fatty acid production is essential in outer membrane biogenesis.
E. coli possesses only three types of phospholipids in its membrane; phosphatidylethanolamine (PE) which comprises the bulk (about 75%), phosphatidylglycerol (PG), and cardiolipin (CL) which represents 15 -20% and 5 -10% respectively (1). This section provides only a brief description of reaction steps that occur prior to the commencement of our pathway model (for detailed description of phospholipids synthesis in E. coli, see reviews (1, 2)).
The first committed step in de novo fatty acid biosynthesis is catalyzed by acetyl-CoA carboxylase (2) (Fig. S1 ). Acetyl-CoA carboxylase consists of four subunits which form a highly unstable complex (AccABCD); although this complex can be purified as two subcomplexes (3, 4). The reaction requires ATP and two molecules of acetyl-CoA to produce malonyl-CoA. Malonyl-CoA in E. coli cells are consumed exclusively in the biosynthesis of fatty acids (1). In addition to the requirement for ATP, each protein subunit must be produced in proportionate amounts thus, acetyl-CoA carboxylase is regulated at the level of transcription (5, 6). Furthermore, acyl-acyl carrier protein (acyl-ACP) inhibits the carboxylase activity presumably to prevent an accumulation of excess acyl-ACPs that may not be required for phospholipids synthesis (7).
Malonyl-CoA is then converted to malonyl-ACP by malonyl-CoA:ACP transacylase (FabD) (Fig. S1 ). FabD is specific for malonyl-CoA and is incapable of utilizing acetyl-CoA (2).
Deletion of this gene is lethal to the cell (8) whereas, overexpression of FabD results in decreased amount of palmitoleic acid and elevated levels of cis-vaccenic acid (9). A possible explanation for this observation is that overexpressing FabD would enable malonyl-ACP which has a regulatory effect on FabF to accumulate, and thus, increase the activity of FabF (9). This is because the elongation of palmitoleic acid to cis-vaccenic acid is performed exclusively by FabF (10) (Fig. S2) . The malonyl-ACP produced is condensed with acyl-ACPs for fatty acid elongation by the 3-ketoacyl-ACP synthases (2). There are three 3-ketoacyl-ACP synthases in E. coli; FabB, FabF, and FabH (KASI, KASII, and KASIII) and they are all functionally distinctive.
The initial condensation of malonyl-ACP requires acetyl-CoA and this reaction is performed solely by FabH (11) (Fig. S1 ). Further condensation reactions are conducted exclusively by 
Model architecture
A schematic representation of our model is depicted in Fig. S2 . Our model commences at fatty acid initiation step with the FabH reaction which then leads to the formation β-hydroxydecenoyl-ACP. This meant that we ignored reaction intermediate steps between the actual product of FabH and β-hydroxydecenoyl-ACP (i.e. the 4-, 6-, and 8-carbon steps).
Ignoring these steps was valid since β-hydroxydecenoyl-ACP is a direct substrate for trans-2-decenoyl-ACP production. Trans-2-decenoyl-ACP in turn, represents a key substrate in the metabolic junction of UFA and saturated fatty acids (SFA) synthesis and our model focuses mainly on the distribution of SFA and UFA moieties present in E. coli phospholipids. The consequence of ignoring these steps would have no significant effect on our model output since in reality, perturbation of steps prior to the formation of β-hydroxydecenoyl-ACP would directly affect the pool of trans-2-decenoyl-ACP which in turn, would affect both SFA and UFA levels proportionately.
FabH catalyzes the condensation of acetyl-CoA with malonyl-ACP and is not involved in subsequent fatty acid elongation cycle (11). This enzyme is known to be inhibited by acyl-
ACPs especially palmitoyl-ACP (C16:0) and cis-vaccenoyl-ACP (C18:1) (11).

FabA and FabZ dehydrates β-hydroxydecenoyl-ACP to produce trans-2-decenoyl-ACP.
Under physiological conditions, this reaction step is unfavourable (13). The trans-2-decenoyl-ACP synthesized can either be reduced to decanoyl-ACP (a SFA) by the action of FabI in an essentially irreversible reaction (14), or further isomerized by FabA to produce cis-3-decenoyl-ACP which is the first step in UFA biosynthesis (15). Thus, competition for trans-2-decenoyl-ACP between FabA and FabI most likely influences the relative ratios of SFA and UFA. However, overexpression of FabA does not increase UFA yield because FabB limits UFA synthesis in this case. In fact, FabA overexpression conditions increased the total cellular SFA whilst the UFA levels remained the same (16). This is because, overexpression would increase the concentration of trans-2-decenoyl-ACP, and subsequently result in a faster production of SFA but UFA synthesis rate remain unchanged. Unsurprisingly, overexpression of both FabA and FabB increased the total amount of cellular UFA (17).
Decanoyl-ACP and cis-3-decenoyl-ACP are both utilized as substrates for further rounds of fatty acyl elongation catalyzed by FabB/FabF, FabG, FabA/FabZ, and FabI respectively. One of the key regulation of fatty acid synthesis in E. coli is the transcriptional regulation of fabA and fabB genes (21-23). Both genes have two set of promoters; one which is constitutively expressed, and another which is activated by FadR and repressed by FabR (22,
24-26).
Transcription is repressed in the presence of sufficient UFA which further highlights the dual role of FabA and FabB in UFA synthesis (27) . In addition to the activation of fabA and fabB, FadR is also a repressor of all genes that code for proteins involved in the β-oxidation cycle (28). The LPS pathway arm of our model is similar to that which we described previously with some minor modifications (33). We provide a brief summary here. 
Model equations and parameters
We modelled the interactions between substrates and enzymes under steady-state conditions
for an E. coli cell. With the exception of FabA, FabB, LpxC and WaaA (whose regulation were being studied in our model), we used a fixed concentration for other proteins thus ignoring protein synthesis and degradation, and cell volume growth. Such assumptions are adequate because enzyme concentrations remain relatively constant over the course of the cell cycle. Table S1 lists all parameters employed in our model.
Substrate and enzyme abundance
We kept the levels of UDP-N-acetylglucosamine (UDP-GlcNAc) and CMP-Kdo constant at 2 million molecules (5 mM) much as we did previously (33). We also maintained the levels of acetyl-CoA and G3P at 2 million and 1 million molecules respectively. This led to substrate saturation conditions throughout our simulations. FabH is highly abundant in the cell, modelling complexation is unnecessary because FabH is involved in a single-reaction step as mentioned above.
All kinetic parameters for enzymes involved in the LPS biosynthesis arm of our model have been described in our previous work (33). We modelled the phospholipids pathway reactions using either single-substrate or bi-substrate Michaelis-Menten mechanisms. Our integrated LPS/phospholipids model include reversibility of reactions and several feedback loops which are essential for models to attain a steady-state (49).
We employed a single-substrate reversible Michaelis-Menten kinetics for FabG, FabB, FabF, FabZ, and FabA (50). Here the metabolic flux is converted to product at a pH of 9.0 (in comparison to the optimum pH of FabG in which all substrates were converted to product). The low product formation was as a result of the reaction becoming unfavourable at a pH of 9.0. However, the physiological pH of E. coli is about 7.5 (53), and this led to 70% of products being formed. This suggests that under physiological conditions, the FabG reaction equilibrium constant is 2.3. Since we assume Kms and Kmp to be same, this meant that the equilibrium constant equals the kcatf / kcatr ratio. Thus, we derived kcatr as 536 s The specific activity of FabZ whilst catalyzing β-hydroxy-cis-7-tetradecenoyl-ACP (C14:1)
is similar to that of β-hydroxymyristoyl-ACP ( Figure 6 in (13) ). Consequently, the parameters for FabZ were same for both substrates in our model. There were no available information in the literature to estimate parameters for other cis-unsaturated acyl substrates of FabZ. We assumed similar rates for both saturated and cis-unsaturated acyl substrates of the same chain length. This meant that parameters for 12-carbon and 16-carbon saturated substrates were assigned to 12-carbon and 16-carbon cis-unsaturated substrates respectively.
The reaction affinity of FabA and FabZ towards β-hydroxymyristoyl-ACP is also similar (13). Since they both have similar molecular weight, this indicates they also share similar kcatf values as well. We calculated the FabA kcatf values for β-hydroxydecanoyl-ACP, β-hydroxydodecenoyl-ACP and β-hydroxypalmitoyl-ACP relative to β-hydroxymyristoyl-ACP according to Figure 5 in (13 The reaction equilibrium constant of 0.14 as mentioned above enabled us to derive kcatf..
Although we initially assumed same values for Kms and Kmp, we utilized a Kms value of 0.0001 mM as described below.
We used bi-substrate Michaelis-Menten kinetics for the transfer of fatty acyl moieties to G3P
by PlsB and PlsC. Here, the metabolic flux is The authors also reported similar specific activities for the incorporation of palmitoyl-ACP and palmitoleoyl-ACP. The incorporation of palmitoyl-ACP is also performed exclusively by
PlsB. This therefore suggests that 1 mg of inner membrane fraction (which contains PlsB) whilst utilizing palmitoyl-ACP would result in the same reaction rate as 1 mg of inner membrane fraction (containing PlsC) when catalyzing palmitoleoyl-ACP. Since the molecular weight of PlsB is 3 times that of PlsC (46, 57), this suggests that the PlsC copy number in membrane extract is 3 times that of PlsB (hence, PlsC count per cell is about 4200 molecules). This also suggests that the kcat value for PlsC towards palmitoleoyl-ACP would be 3 times less that for PlsB with palmitoyl-ACP substrate.
Additionally, Goelz and Cronan (38) observed that 32% of fatty acids attached to position-1 of G3P were cis-vaccenic acids (i.e. by PlsB). We ran initial simulations for PlsB using COPASI (50) (1400 copies per cell (46)) with saturation levels of palmitoyl-ACP and cisvaccenoyl-ACP and parameters described above. We observed that when there was no We used single-substrate Michaelis-Menten kinetics with inhibition for the FabI enzyme for all substrates. In this case, the metabolite flux is
where Ki is the inhibition constant, [P] is the concentration of palmitoyl-ACP, and the other parameters are the same as in eq. 2.
We used same parameters for trans-2-tetradecenoyl-ACP (C14:0) and trans-2-dodecenoyl- and also derived its Km parameter relative to trans-2-dodecenoyl-ACP from Figure 6 of (58).
Finally, Heath and Rock (35) observed that at a palmitoyl-ACP concentration of 400 µM, the FabI reaction rate was inhibited by 92%. If we assume non-competitive inhibition and excess substrate conditions, we can derive the Ki value as 0.035 mM.
We modelled the FabH reaction step using an irreversible single-substrate Michaelis kinetics with dual acyl-ACP (palmitoyl-ACP and cis-vaccenoyl-ACP) inhibition. Here, the metabolite flux is
where Ki* is inhibition constant arising from cis-vaccenoyl-ACP ([P*]) and other parameters are same as eq. 3.
We initially derived the FabH kcat value of 3.28 s -1 from the reported specific activity (11) but knew at this point that this parameter would be insufficient to produce sufficient β-hydroxydecenoyl-ACP for SFA and UFA synthesis (the FabH molecule count is 1320 per cell (45) which suggests a maximum production of 8 million products whereas, approximately 20 million fatty acids are generated in vivo (41)). This is unsurprising as it has been suggested previously that there are other enzymes capable of replacing FabH (60).
Consequently, we increased the kcat value to 12 s -1 . We estimated the inhibition constants for palmitoyl-ACP and cis-vaccenoyl-ACP inhibitors as 0.1 mM and 0.067 mM from Heath and Rock (11) much as we did for FabI above.
LpxK catalytic activation and inactivation
We modelled the activation of LpxK from an inactive to an active state using mass action kinetics according to
where k is the phospholipids-independent activation constant, Ka is the phospholipids- 
Simulations
We simulated our LPS and phospholipids synthesis model using deterministic methods. Our primary tool was the COPASI software (50). We assumed a 6.7 x10 -16 litre cell volume (62).
Our simulations represented an E. coli cell generation under optimal growth conditions which is 1800 s (63). We have identified previously (33) that using stochastic simulations and accounting for stochasticity had negligible effect on the results due to the high copy numbers of all model components which justified the use of deterministic simulations. Our model has been deposited in the BioModels database and assigned the identifier MODEL1601080000.
Model adjustment
Our initial model parameters described above were unable to either achieve the appropriate SFA/UFA ratio or replicate some published experimental findings. This was as a result of limitations in the following areas;
FabA isomerase and FabZ kinetics
Initial simulations resulted in excess SFA and little or no UFA. This was solely due to FabI outcompeting FabA isomerase for trans-2-decenoyl-ACP substrate which led to an accumulation of SFA substrates. We solved this problem by reducing the Kms value of FabA isomerase towards trans-2-decenoyl-ACP to 0.0001 mM which resulted in SFA occupying 50% of total fatty acids. Indeed, there were no reported Km parameters for the isomerization of trans-2-decenoyl-ACP in the literature so it is unsurprising that our initial estimate was inadequate.
Although we had obtained 50% SFA yield, a bottleneck in the UFA arm of the pathway ensured an insufficient production of UFA resulting from accumulation of substrates of FabZ.
Again, this is understandable given there were also no reported parameters for cis-unsaturated substrates of FabZ in the literature as mentioned earlier. We resolved this problem by increasing both the kcatf and kcatr parameters (so the equilibrium constant remained the same)
for the 14, 16 and 18-carbon unsaturated substrates by 3 folds. 
FabB activity towards cis-3-decenoyl-ACP
Model results
FabZ inhibition and overexpression
Zeng at al. were decreased by 40% when FabZ was inhibited and consequently, the amount of LPS being produced was also reduced by 40%. We observed the LpxK catalytic activation rate was reduced by 50% which enabled lipid A disaccharide to accumulate and negatively feedback on LpxC degradation. Our model strain had excess SFA and could barely synthesize UFA due to the absence of an essential FabZ role at dehydrating cis-containing β-hydroxyacylsubstrates. Despite this, we observed no accumulation of FabZ substrates due to the readily reversible nature of the FabZ reactions. However, the production of SFA was able to occur because FabA was active. Nevertheless, the dehydratase role of FabZ in UFA synthesis cannot be complemented by FabA (13). We also observed an upregulation in FabA and FabB concentrations but these had no effect at elevating the concentrations of UFA because FabZ became the rate-limiting step.
On the other hand, the steady-state concentration of LpxC was increased by 2.6 fold when FabZ was overexpressed in our model (Fig. S3A) . However, we observed LPS levels were reduced by 70%. Since cells become non-viable when LPS amounts are reduced by more than 50% (66), overexpression of FabZ would result in a lethal effect to the cell in agreement with data presented in Zeng et al. (34) . Regarding the fatty acid profile, the production of SFA was slightly enhanced while UFA amounts remained the same. Although Lee et al. (67) had reported that overexpression of FabZ increases the proportion of UFA, their data exhibited this phenomenon only after prolonged growth (i.e. stationary phase) whereas, our model represents the exponential or steady-state growth phase of E. coli. In fact, their results indicated that when the cells were harvested early, SFA was increased and UFA decreased.
Thus, in this respect, our FabZ model is compatible with their experiments. Despite the slight increase in SFA levels in our model, we did not observe an up-regulation of FabA or FabB.
The role of FabA and FabB in UFA biosynthesis
As mentioned above, cellular requirement for UFA results in an upregulation of both fabA and fabB genes which enhances UFA yield. However, sole overexpression of fabA increases SFA synthesis rather than UFA synthesis (16, 17). We tested this phenomenon in our model as presented in Figure S3B . Our model results agree qualitatively with experimental evidence presented in Clark et al. (16) . The slight quantitative disparity may arise since the experimental results used for comparison were carried out at 42°C whereas, our model parameters represent optimum conditions. Alternatively, the quantitative differences could arise due to strain-to-strain fatty acids variability.
Overexpression of FabH
In Tsay et al. (68), it was shown that overexpression of FabH increased the cellular concentration of SFA by 16%. Testing this perturbation in our model was relatively straightforward. We observed a 10% increase in SFA levels when the FabH count was increased by 100 folds in close agreement with the experiments. Furthermore, our model showed an increase in the expression levels of FabA and FabB; however, expression of the latter was not as pronounced as FabA.
Fig. S3. Model results.
Model conditions were those depicted in Fig. S2 and using parameters presented in Table S1 . 
Summary
We have developed a computational model for the outer membrane of E. coli, drawing parameters from the literature, and making estimates where possible. Our model agrees qualitatively with experimental data and to some extent, quantitatively. However, our model may be inadequate for testing certain pathway perturbations. For instance, there were no specific parameters for FabG for any of the substrates studied in our model so our estimate may only be adequate under wild-type conditions where FabG does not limit pathway flux.
Also, as stated above, FadR is a global regulator of certain genes involved in fatty acid biosynthesis and degradation. Apart from the transcriptional activation of fabA and fabB, the other roles of FadR are outside the scope of our work hence, our model may be inappropriate at studying the effect of FadR dynamics on fatty acid synthesis. 
EXPERIMENTAL PROCEDURES Bacterial strains and growth conditions
The E. coli strains and plasmids used in our experiments along with their relevant characteristics are presented in Table S2 . Unless stated otherwise, cells were grown in LB medium (10 g tryptone, 5 g yeast extract, 5 g NaCl per litre). When required, antibiotics were used at the following concentrations; 20 µg/ml chloramphenicol, 30 µg/ml kanamycin and 100 µg/ml ampicillin. Protein expression was induced with either L-arabinose or IPTG as appropriate when required. 
* Gene mutations highlighted in bold represent genes involved in fatty acid production/regulation. sfhC is a synonym for fabZ. The mutation fabA203(p) leads to the creation of a novel fabA promoter.
Growth conditions for fatty acid biosynthetic mutants
Strain JP1111 (fabI (ts)) cells were grown at 30°C to an OD600 of 0.15. Part of the culture was transferred to 42°C and grown for 150 min. Growth ceased after 2 generations at the nonpermissive temperature. Strain CY288 (fabB200, fabB (ts)) was prepared as above except that cells were grown in a modified LB broth (5 g tryptone, 2.5 g yeast extract, 2.5 g NaCl) and growth ceased after 2 generations at 42°C. Overnight culture of strain CY53 (fabA(ts)) was grown directly either at 30°C or 42°C. At the latter temperature, growth ceased after 3
generations.
Preparation of cell extracts
In the case of the temperature-sensitive mutants, isogenic strains were harvested and re- Unless specified otherwise, cell extracts for other strains were prepared as described previously (34, 75). Briefly, an overnight culture was inoculated into fresh LB grown to midlog phase (OD600 = 0.5). The respective cultures were normalized to the same OD600 of 0.5. 3 ml of normalized culture was centrifuged at maximum speed for 1 min and the cell pellets resuspended in 100 µl of TE buffer containing 1x Laemmli sample buffer (Bio-Rad). The samples were heated for 10 min prior to centrifugation for 5 min. The supernatants were collected for Western blot analysis.
Cell extract preparation for in vitro and in vivo LpxC analyses
Both ftsH knockout mutant and W3110 strain (wild-type) containing a plasmid bearing the lpxC gene were grown at 30°C. 0.1% L-arabinose was included in the growth medium of the latter to induce protein expression. Cells were harvested at mid-log phase, re-suspended in 
Western blot
20 µl of each normalized sample were loaded onto a 10% SDS-polyacrylamide gel. For samples subjected to the Bradford assay, equal amounts of protein were loaded onto each well. Following electrophoresis, proteins were transferred to a PVDF membrane using the Bio-Rad Trans-Blot Turbo system. An LpxC antiserum generated in rabbit (a kind gift from Prof. Franz Narberhaus) and a secondary anti-rabbit peroxidase-linked antibody (Sigma, UK)
were used for immunodetection at dilutions of 1:20000 and 1:10000 respectively. The WaaA construct expressed from the plasmid contains a His-tag attached to its N-terminus.
Consequently, WaaA was immunoblotted using a 6x-His epitope tag primary antibody (Pierce) generated in mouse (1:6000) and a secondary anti-mouse alkaline phosphatse-linked (AP) antibody (1:8000). Blots were developed using the ECL chemiluminiscent reagents (Bio-Rad) or AP substrate kit (Bio-Rad) as appropriate. Signals were detected using the ChemiDoc MP system (Bio-Rad). Bands were quantified using the ImageJ software.
LPS quantification
Heptose assay
Heptose levels in LPS were determined by the method described previously ( g/mol respectively), the amounts were calculated.
Phenotypic characterization on agar plates
E. coli strains containing the plasmid bearing the waaA gene were grown to an OD600 of 0.2 and serial dilutions from 10 -1 to 10 -4 were prepared. 2 µl of the dilutions were spotted on LB agar plates containing chloramphenicol and when required, IPTG was used to induce expression. The plates were incubated at 30°C overnight.
Fatty acid analysis
Fatty acid extraction
Fatty acid extraction was performed essentially as described by Kurkiewicz et al (79). 40 ml of normalized bacteria cells harvested at an OD600 of approximately 0.5 were centrifuged and the pellets heated with 3M NaOH (1 ml) for 40 min at 90°C in a water bath. 2ml of 3.25M
HCl was added and heated further for 10 min at the same temperature. After cooling, fatty acids were extracted 3 times using 1ml of hexane-diethyl ether mixture (1:1). The organic layers were separated by centrifugation for 5 min at 2400 x g. The obtained fatty acids were evapourated under vacuum prior to the derivation step.
Preparation of 3-pyridylcarbinol (picolinyl) ester derivatives
The derivatives were prepared as described previously (80). The extracted fatty acids were heated with 20 µl of thionyl chloride for 10 min at 99°C. The residual thionyl chloride was evapourated under a stream of nitrogen gas and a solution of 20% 3-(hydroxymethyl) pyridine in acetonitrile (10 µl) was added. The mixture was heated for 1 min at 99°C. 500 µl of hexane was added prior to GCMS analysis.
Gas chromatography-mass spectrometry
GCMS analyses were performed using an Agilent GC 7890A and EI/CI MSD 5975C models.
Chromatographic separations were performed using a capillary column (30 m, 0.25 mm i.d., 0.25 µm film thickness) and helium was the carrier gas. The temperature program of the oven used were those previously described by Oursel et al. (64) ; initial temperature at 200°C, held for 1 min, raised to 240°C at 8°C min -1 , then ramped to 300°C at 2°C min -1 .
Peak identities were confirmed from their electron ionization (EI) mass spectra, and comparison with retention times of known standards.
SUPPLEMENTARY RESULTS
Overexpression of fabA enhances LpxC degradation
When strain DC170 (fabAup) which overexpresses fabA was grown at 30°C, there were no differences in LpxC levels relative to the control strain (W3110). However, at 42°C, we observed a rapid degradation of LpxC (Fig. S4A) . Clark et al. (16) had reported previously that saturated fatty acid levels are not elevated in strains overexpressing fabA at temperatures of 30°C or less; however, at optimum temperature and especially 42°C, saturated fatty acids concentration were significantly increased. As we have stipulated in the main article text, excess flux of substrates into the saturated fatty acid pathway and subsequently the LPS pathway enhances LpxC degradation which most likely explains the results presented in Fig.   S4A . Furthermore, we observed that the amount of LPS synthesized at both temperatures by strain DC170 were similar to those of wild-type (Fig. S4B ). In particular, at 42°C in which pathway substrate flux was increased, an increment in LPS relative to wild-type is not expected because LpxK becomes the rate-limiting step. Instead, lipid A disaccharide would accumulate leading to a rapid degradation of LpxC (Fig. S4A ).
We also observed that overexpression of lpxC was highly toxic in strain DC170 and under such condition, cells spend a significant length of time in the lag growth phase presumably to degrade excess LpxC prior to reproduction (Fig. S4C ). This also supports the claim that LpxC level must be lowered under fabA overexpression conditions.
Overexpression of waaA is toxic to cells
When we overexpressed waaA, cell growth was inhibited (Fig. S5B) . A similar finding was observed previously for LpxC in studies by Fuhrer et al. in which overexpression of a functional lpxC gene resulted in cell toxicity (32). The authors also observed that overexpression of non-functional lpxC did not result in cell toxicity. Therefore, it is plausible that under unregulated WaaA conditions, such as during overexpression, increased metabolic activity occurs which is undesirable to the cell. Additionally, when we reduced the LPS pathway flux by inhibiting LpxC using sub-MIC concentration of CHIR-090, overexpression of waaA under this condition did not prevent cellular toxicity (Fig. S5C ). This provided an indication that unregulated production of WaaA would also result in increased metabolic activity which may be independent on LPS production rate. In fact, the toxicity induced by waaA overexpression and LpxC inhibition was additive (Fig. S5C) . were transformed with a plasmid bearing the lpxC gene (pBO110) and protein expression was induced overnight at 30°C using 0.1% L-arabinose. Overnight cells were transferred to fresh broth (without inducer) and incubated at 42°C. Growth rate was monitored (left) and after 90 min, part of the culture was harvested, and cell extracts subjected to the Bradford assay prior to Western blot analysis (right). The concentration of CHIR-090 utilized was 0.02 µg/ml. The combined toxicity resulting from waaA overexpression and CHIR-090 treatment is additive (right). E. coli wild-type (W3110) cells containing a plasmid bearing the waaA gene were grown at 37°C to an OD600 of 0.1 prior to addition of IPTG to induce expression. Growth was allowed to continue for 2 h and the cultures were normalized according to their density prior to harvesting.
